series-a
Stage
2013
Founded
2
Investors
About
LENZ Therapeutics is a pharmaceutical company focused on the commercialization of VIZZ™ (aceclidine ophthalmologic solution) 1.44%, the first and only FDA-approved aceclidine-based eye drop for the treatment of presbyopia.
Explore Lenz Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.